The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population- an updated meta-analysis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population- an updated meta-analysis
Authors
Keywords
Acute Phase, Chronic phase, Cilostazol, Meta-analysis, Stroke
Journal
BMC Neurology
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-12-20
DOI
10.1186/s12883-014-0251-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differences in Ischemic and Hemorrhagic Recurrence Rates among Race-Ethnic Groups in the PRoFESS Secondary Stroke Prevention Trial
- (2014) Conrado J. Estol et al. International Journal of Stroke
- Gastrointestinal symptoms in low-dose aspirin users: a comparison between plain and buffered aspirin
- (2014) J. Jaspers Focks et al. Netherlands Heart Journal
- Meta-Analysis of Cilostazol Versus Aspirin for the Secondary Prevention of Stroke
- (2013) James J. DiNicolantonio et al. AMERICAN JOURNAL OF CARDIOLOGY
- Cilostazol for the Prevention of Acute Progressing Stroke: A Multicenter, Randomized Controlled Trial
- (2013) Hiroaki Shimizu et al. Journal of Stroke & Cerebrovascular Diseases
- Grading quality of evidence and strength of recommendations in clinical practice guidelines Part 3 of 3. The GRADE approach to developing recommendations
- (2011) J. L. Brożek et al. ALLERGY
- Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): A Randomized Double-Blind Non-Inferiority Trial
- (2011) Yong-Seok Lee et al. CEREBROVASCULAR DISEASES
- Cilostazol combined with aspirin prevents early neurological deterioration in patients with acute ischemic stroke: A pilot study
- (2011) Tomomi Nakamura et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Cilostazol, Not Aspirin, Reduces Ischemic Brain Injury via Endothelial Protection in Spontaneously Hypertensive Rats
- (2011) Naoki Oyama et al. STROKE
- Cilostazol Reduces the Risk of Hemorrhagic Infarction After Administration of Tissue-Type Plasminogen Activator in a Murine Stroke Model
- (2011) Yukiko Kasahara et al. STROKE
- Primary and Secondary Prevention of Ischemic Stroke
- (2010) Maurizio Paciaroni et al. EUROPEAN NEUROLOGY
- Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial
- (2010) Yukito Shinohara et al. LANCET NEUROLOGY
- Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies
- (2009) J. L. Brożek et al. ALLERGY
- Grading quality of evidence and strength of recommendations in clinical practice guidelines
- (2009) J. L. Brożek et al. ALLERGY
- Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial
- (2009) J.-H. Lee et al. EUROPEAN JOURNAL OF NEUROLOGY
- Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis
- (2009) Sarah T Pendlebury et al. LANCET NEUROLOGY
- Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke
- (2009) Jian-Jun Guo et al. Neuroscience Bulletin
- Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study
- (2008) Yining Huang et al. LANCET NEUROLOGY
- Racial Differences in Vascular Risk Factors and Outcomes of Patients With Intracranial Atherosclerotic Arterial Stenosis
- (2008) Salina P. Waddy et al. STROKE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started